Carmell Therapeutics Corporation Class A Common Stock Made Big Gain
Tue, Aug 15, 2023 at 07:34 PM
Carmell Therapeutics Corporation Class A Common Stock (CTCX:NASDAQ) jumped higher at $3.56, a gain of 27.6%. On Tue, Aug 15, 2023, CTCX:NASDAQ hit a New 2-Week High of $3.56. The stock appeared on our News Catalysts scanner on Wed, Aug 09, 2023 at 05:33 PM in the 'MERGER' category. From Tue, Aug 01, 2023, the stock recorded 50.00% Up Days and 18.18% Green Days
About Carmell Therapeutics Corporation Class A Common Stock (CTCX:NASDAQ)
Alpha Healthcare Acquisition Corp III is a blank check company.
Top 10 Gainers:
- T2 Biosystems, Inc. (TTOO:NASDAQ), 51.56%
- Paranovus Entertainment Technology Ltd Ord (New) (PAVS:NASDAQ), 36.33%
- Tiziana Life Sciences PLC (TLSA:NASDAQ), 33.94%
- Grove Collaborative Holdings Inc. Class A (GROV:NYSE), 30.14%
- Electrameccanica Vehicles Corp. (SOLO:NASDAQ), 29.9%
- Carmell Therapeutics Corporation Class A Common Stock (CTCX:NASDAQ), 27.6%
- Peak Bio Inc Com (PKBO:NASDAQ), 27.48%
- Marker Therapeutics, Inc. (MRKR:NASDAQ), 25.75%
- Siyata Mobile Inc. (SYTA:NASDAQ), 24.4%
- Genesis Unicorn Capital Corp. (GENQ:NASDAQ), 24.05%